Ciena upgraded to Overweight following 21% DeepSeek-related plunge: JP Morgan
Ciena (NYSE:CIEN) was upgraded to Overweight from Neutral by J.P. Morgan following a 21% plunge on Monday related to DeepSeek ...
J.P. Morgan Sticks to Their Buy Rating for Compagnie de Saint Gobain (COD)
J.P. Morgan analyst Elodie Rall maintained a Buy rating on Compagnie de Saint Gobain (COD – Research Report) today and set a price target of ...
Benzinga.com1mon
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
In 2024, biopharma stocks rose by 9.6%, falling short of the S&P 500's 28.5% surge. However, JP Morgan analysts maintain a positive outlook for several key players. Eli Lilly And Co. LLY ...
alternativeswatch21h
J.P. Morgan's Global Alternatives Outlook flags investment opportunities amid market shifts
J.P. Morgan Asset Management's latest Global Alternatives Outlook highlights opportunities across PE, credit, real estate, ...
Hosted on MSN1mon
J.P. Morgan’s top Financial stocks for 2025
and lower gas prices,” J.P. Morgan analysts said. “All of these are a tailwind to originations growth, disposable income, and credit performance for OneMain’s (OMF) target market ...
J.P. Morgan Sticks to Their Buy Rating for SAP SE (0NW4)
J.P. Morgan analyst Toby Ogg maintained a Buy rating on SAP SE (0NW4 – Research Report) today and set a price target of €260.00. The company’s ...